Dimensional Fund Advisors
FNCH

Dimensional Fund Advisors’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Dimensional Fund Advisors’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-335
Closed -$17K – 3531
2022
Q3 		$17K Buy
+335
New +$23.3K ﹤0.01% 3467

Other funds holding FNCH

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Dimensional Fund Advisors's FNCH Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q4 2022, closing a stake of 335 shares — an estimated $17K sold.

Dimensional Fund Advisors first reported a position in FNCH in Q3 2022 and held it in 1 quarter. The position peaked at $17K in Q3 2022. 40 funds tracked by Wall St. Rank hold FNCH as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 335 Finch Therapeutics Group, Inc. Common Stock shares in Q4 2022, an estimated $17K.
  • Dimensional Fund Advisors first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Dimensional Fund Advisors's Finch Therapeutics Group, Inc. Common Stock position peaked at $17K in Q3 2022.
  • 40 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.